genprowebdirectory
  • GEN Edge
    • Featured News
    • Multimedia
  • News
  • Insights
    • Trends for 2020
    • Trends for 2021
    • Trends for 2023
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • GEN Edge
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
    • Videos
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Eye Disorders

      Prime Editing Reverses Vision Loss in Mice

      3D illustration Rendering of binary code pattern.Futuristic Particles digital Landscape wave Abstract background for business,Science and technology
      Artificial Intelligence

      AI-Proofing Workflows in Drug Development

      Lung Cancer
      Cancer

      New Drug Combo Reduces Lung Tumors in Mice

      Corn crop
      AgBio

      Gene Discovery May Help Effort to Breed Climate Resilient Crops

      RNA strands consisting of nucleotides important for protein bio-synthesis
      Cancer

      Novel Approach Delivers Therapeutic RNA Molecules to Selectively Target Cells

  • Insights
    • AllTrends for 2020Trends for 2021Trends for 2023
      Abstract Colorful Blue Radial Glitch Chromatic Holographic Background
      Cancer

      Lightspeed’s Jonathan MacQuitty and the Laws of Biotech Relativity

      scientists workin
      Biologics

      Biologics Manufacturing without the Cells

      Bioprocessing

      Bio-Inspired Coatings Could Make Cell Activation More Efficient in Therapy Production

      Bioprocessing

      Vortex-Focusing Microfluidics Yields Precisely Sized Liposomes at Scale

  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • GEN Edge
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
    • Hand Shake Meetings
      Drug Discovery

      Seven Biopharma Trends to Watch in 2023

      NIH Building
      A-Lists

      Top 50 NIH-Funded Institutions of 2022

      Bristol Myers Squibb building
      A-Lists

      Top 10 U.S. Biopharma Clusters

      Biomarker
      A-Lists

      Top 10 Spatial Biology Companies

      A-Lists

      Top 25 Biotech Companies of 2022

  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
    • Videos
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home Eye Disorders Page 2

Eye Disorders

  • 10x Genomics
  • A-Lists
  • AgBio
  • Age-Related Disorders
  • Aging
  • AGTC
  • alcohol
  • Alexandria Real Estate Equities
  • Allergic Diseases
  • Application Notes
  • Artificial Intelligence
  • Autoimmune Disorders
  • Bacterial Diseases
  • Bacteriophage
  • Base Editing
  • Bayer
  • Biodefense/Bioterrorism
  • Bioethics
  • Biomarker Discovery
  • BioNTech
  • BioPerspectives
  • Blockchain
  • Blood Disorders
  • Boehringer Ingelheim
  • Bone disorders
  • Brexit
  • Bristol-Myers Squibb
  • Cardiovascular Disease
  • Careers
  • Celgene
  • Cell Analysis
  • Cell Biology
  • Cell Culture
  • Cell Line Development
  • Cell Signaling
  • Cell Therapy
  • Cellular Analysis
  • China
  • Chromatography
  • Circadian Rhythm
  • Commentary
  • Compound Synthesis
  • Computational Biology
  • Computer Simulation
  • COVID-19 Candidates
  • CRISPR
  • CRISPR/Cas9
  • Danaher
  • Developmental Disorders
  • DNA Repair
  • Drug Resistance
  • Ear Disorders
  • Economic development
  • Education and training
  • Electrophoresis
  • Eli Lilly
  • Employment Trends
  • Endocrine Disorders
  • Evolution
  • Extracellular Matrix
  • Eye Disorders
  • Fill and Finish
  • Financing
  • Flow Cytometry
  • Forensics
  • Fungal Diseases
  • Gastrointestinal Disorders
  • GEN 40
  • GEN Edge
  • Genentech
  • Genetic Disease Testing
  • Genetics
  • Glycan Analysis
  • Glycoproteins
  • GWAS
  • Hematologic Conditions
  • Histology
  • HPLC
  • Hypertension
  • Imaging
  • Immunoassay
  • Immunochemistry
  • Immunology
  • In-vitro Fertilization
  • Industry News
  • Inflammatory Diseases
  • Information Management
  • Insights
  • interleukin
  • Ion Channels
  • Kidney Diseases
  • Kinases
  • Literature Review
  • Liver Diseases
  • Lung Cancer
  • Lung Diseases
  • Magazine
  • Marijuana
    Latest
    • Latest
    • Featured posts
    • Most popular
    • 7 days popular
    • By review score
    • Random
    Eye Disorders

    Prime Editing Reverses Vision Loss in Mice

    Eye Disorders

    StockWatch: Apellis Wows Analysts with First FDA Approval for GA Therapy

    Girl Undergoing Eye Examination
    Eye Disorders

    Early Anti-VEGF Treatment of Diabetic Retinopathy Does Not Benefit Visual Acuity, Study Finds

    Eye Disorders

    Andelyn Biosciences and Odylia Therapeutics Partner to Manufacture Novel Gene Therapy for Vision Loss

    Eye Disorders

    Genetic Risk Factor for AMD Identified by Combining Experimental and GWAS Data

    Eye Disorders

    Map of DNA Organization in Human Retina Cells Points to Causal...

    Eye Disorders

    Novel Technique May Lead to New Retinal Disease Treatments

    Eye Disorders

    Adaptive Optics Reveals Cellular Changes in Genetic Blindness Disorder

    Eye Disorders

    Potential Gene Therapy Developed for Childhood Blinding Disease

    Illumina

    StockWatch: Illumina Bounces Back After FTC Win, EU Loss

    NY Mets owner at Citi Field
    Neurological Disorders

    StockWatch: Minerva’s a Home Run with N.Y. Mets Owner

    Eye Disorders

    Mechanism of Glaucoma Protection by Alzheimer’s APOE4 Risk Gene Unravelled

    Progeria
    Eye Disorders

    Targeting LINE-1 RNA Might Prove Therapeutic for Premature Aging Syndromes

    Eye Disorders

    Vision in Humans Restored Using Cornea Implants Bioengineered from Pig’s Skin

    retinal pigment epithelium cells
    Eye Disorders

    Macular Degeneration Molecular Signature May Aid Diagnosis, Treatment

    123...32Page 2 of 32

    Recently Featured

    Prime Editing Reverses Vision Loss in Mice

    Prime Editing Reverses Vision Loss in Mice

    AI-Proofing Workflows in Drug Development

    AI-Proofing Workflows in Drug Development

    Gene Discovery May Help Effort to Breed Climate Resilient Crops

    Gene Discovery May Help Effort to Breed Climate Resilient Crops

    Novel Approach Delivers Therapeutic RNA Molecules to Selectively Target Cells

    Novel Approach Delivers Therapeutic RNA Molecules to Selectively Target Cells

    Read the Digital Edition

    Explore

    • About GEN
    • Contact GEN
    • GEN Staff
    • Editorial Guidelines
    • Reprints and Permissions
    • Scientific Advisory Board

    Advertise

    • Media Kit and Planning Calendar
    • Magazine Advertising
    • Website Banner Advertising
    • eNewsletter Advertising
    • Webinar Sponsorship
    • eBook Advertising
    • List Rental
    • Advertising Terms and Conditions

    Resources

    • Get the GEN Magazine
    • Get the GEN Email Newsletter
    • Inside Precision Medicine
    • New Products
    • Videos
    • Webinars
    • Podcasts
    • Privacy Policy
    • Home
    • Terms of Service
    • Privacy Policy
    • Cookie Policy
    • Mary Ann Liebert, Inc.
    Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
    sponsored
    Scroll Up